Posts Tagged Pharma Financings

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on CymaBay Therapeutics

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. CymaBay Therapeutics, formerly known as Metabolex, develops drugs to treat diabetes and related metabolic disorders. It plans to raise $84.5 million in a secondary public […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on AveXis, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AveXis, Inc., develops gene therapies for the treatment of rare and orphan neurological genetic diseases. It plans to raise $234.5 million in a secondary public […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on AmpliPhi Biosciences Corporation

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AmpliPhi Biosciences, (formerly known as Targeted Genetics Corporation), develops gene-based products for the treatment of acquired and inherited diseases. It raised $9.1 million in a […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on ContraVir Pharmaceuticals, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. ContraVir Pharmaceuticals is a U.S. public bio/pharmaceutical company that develops and commercializes targeted antiviral therapies for the treatment of Hepatitis B, shingles and shingles pain. […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on BioCryst Pharmaceuticals, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. BioCryst Pharmaceuticals is a U.S. public bio/pharmaceutical company that discovers drugs for the treatment of infectious diseases, inflammatory diseases and cancer. It plans to raise […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Aldeyra Therapeutics, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Aldeyra Therapeutics is a U.S. public bio/pharmaceutical company that develops potent, small molecule, irreversible aldehyde traps for the treatment of diseases caused by inflammation and […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Zynerba Pharmaceuticals, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Zynerba Pharmaceuticals is a U.S. public bio/pharmaceutical company that focuses on developing transdermal cannabinoid treatments for patients with high unmet medical needs. It has raised […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Clearside Biomedical, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Clearside Biomedical is a U.S. public bio/pharmaceutical company that develops and commercializes therapeutic products using an ocular microinjection platform to target the individual compartments of […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Synthetic Biologics, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Synthetic Biologics, formerly known as Adeona Pharmaceuticals, is a U.S. public bio/pharmaceutical company that develops late-stage, orally available, small molecule drugs for the treatment of […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Collegium Pharmaceutical, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Collegium Pharmaceutical is a U.S. public bio/pharmaceutical company that focuses on late-stage development and commercialization of pharmaceuticals for the treatment of CNS, respiratory and skin-related […]

Learn more